
Neuroactive Antiretroviral Drugs Do Not Influence Neurocognitive Performance in Less Advanced HIV-Infected Patients Responding to Highly Active Antiretroviral Therapy
Author(s) -
Maria Letizia Giancola,
Patrizia Lorenzini,
Pietro Balestra,
Dora Larussa,
Francesco Baldini,
Angela Corpolongo,
Pasquale Narciso,
Rita Bellagamba,
Valerio Tozzi,
Andrea Antinori
Publication year - 2006
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/01.qai.0000197077.64021.07
Subject(s) - neurocognitive , medicine , odds ratio , regimen , confidence interval , reverse transcriptase inhibitor , antiretroviral therapy , antiretroviral drug , cerebrospinal fluid , human immunodeficiency virus (hiv) , viral load , immunology , gastroenterology , cognition , psychiatry
To analyze the effect of antiretroviral therapy, including drugs that have good penetration in cerebrospinal fluid (CSF), on neuropsychologic performance.